Diagnosis requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can help to match the needs of a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised treatment programs for the treatment and management of vascular disease type 1 typically include drug therapy, rehabilitation interventions, regular follow-up, and multidimensional management.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat blood tumor diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of vascular hematoma type 1.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.